SCHEMBL20074318

SCHEMBL20074318

CC(C)c1c(-c2ccc(C(=O)N(C)C)cc2)[nH]c2ncnn2c1=O

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM5B Q9UGL1 2/20 0.51
TLR8 Q9NR97 3/20 0.43
TLR7 Q9NYK1 3/20 0.43
TSHR P16473 4/20 0.38
PDE9A O76083 1/20 0.38
TLR9 Q9NR96 1/20 0.37
NCOA1 Q15788 1/20 0.36
NCOA3 Q9Y6Q9 1/20 0.36
MMP2 P08253 1/20 0.36
MMP9 P14780 1/20 0.36
MMP8 P22894 1/20 0.36
CLK4 Q9HAZ1 3/20 0.36
CYP2D6 P10635 3/20 0.36
ALDH1A1 P00352 2/20 0.36
SIRT5 Q9NXA8 1/20 0.36
CYP1A2 P05177 4/20 0.36
CYP3A4 P08684 4/20 0.36
ALOX15 P16050 2/20 0.36
CYP2C19 P33261 2/20 0.36
HSD17B10 Q99714 2/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20074207 0.85 KDM5B (0.39) KDM5BTLR8TLR7TSHRTLR9
SCHEMBL21721717 0.85 KDM5B (0.46) KDM5BTLR8TLR7TSHRTLR9
SCHEMBL20074254 0.84 KDM5B (0.51) KDM5BTLR8TLR7TSHRTLR9
SCHEMBL20074113 0.82 KDM5B (0.44) KDM5BTSHRALDH1A1SIRT5TDP1
SCHEMBL20074328 0.82 KDM5B (0.44) KDM5BTSHRCYP1A2CYP2C19LMNA
SCHEMBL20074320 0.81 KDM5B (0.46) KDM5BTLR8TLR7TSHRTLR9
SCHEMBL20074331 0.81 KDM5B (0.43) KDM5BTLR8TLR7TSHRTLR9
SCHEMBL21721741 0.80 KDM5B (0.48) KDM5BTSHR
SCHEMBL21721761 0.80 KDM5B (0.46) KDM5BTSHRALDH1A1SIRT5HPGD
SCHEMBL21681712 0.80 CCNB2 (0.49) KDM5BTLR8TLR7TSHRALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3525785-B1 KDM5 INHIBITORS MERCK SHARP & DOHME LLC (US) 2025-08-27 EP claimed
EP-3525785-B1 KDM5 INHIBITORS MERCK SHARP & DOHME LLC (US) 2025-08-27 EP disclosed
US-10975084-B2 KDM5 inhibitors MERCK SHARP & DOHME CORP. (US) 2021-04-13 US disclosed
US-20200048258-A1 KDM5 INHIBITORS MERCK SHARP & DOHME CORP. (US) 2020-02-13 US disclosed
WO-2018071283-A1 KDM5 INHIBITORS MERCK SHARP & DOHME CORP. (US) 2018-04-19 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200048258-A1 KDM5 INHIBITORS KDM5A, KDM5B, KDM5C KDM5B 2/4885TLR8 3599/4885TLR7 2968/4885
US-10975084-B2 KDM5 inhibitors KDM5A, KDM5B, KDM5C KDM5B 2/4885TLR8 3599/4885TLR7 2968/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.